# Questions and Answers on Quality Related Controlled Correspondence Guidance for Industry:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/questions-and-answers-on-quality-related-controlled-correspondence-guidance-for-industry-guidance-for-industry/36e0e984-b134-47b6-bee8-6f25aa0282c1

> FDA guidance document: Questions and Answers on Quality Related Controlled Correspondence Guidance for Industry:  Guidance for Industry. Issue date: September 20, 2021. Get complete insights and analysis.

---

## Details

- Title: Questions and Answers on Quality Related Controlled Correspondence Guidance for Industry:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2021-09-20
- Last Changed: 2021-10-04
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2017-D-6821">FDA-2017-D-6821</a>

## Related Documents

- [Controlled Correspondence Related to Generic Drug Development](https://www.globalkeysolutions.net/guidances/guidance-document/controlled-correspondence-related-to-generic-drug-development/55babf6e-6cea-4e6c-80f6-3892feff9aab)
- [Orange Book Questions and Answers Guidance for Industry:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/orange-book-questions-and-answers-guidance-for-industry-guidance-for-industry/8492a175-773f-4d3e-a92c-aec1f10c8bda)
- [Eosinophilic Esophagitis: Developing Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/eosinophilic-esophagitis-developing-drugs-for-treatment-guidance-for-industry/e454ac25-939f-4e9c-a8f1-b2613feff0b3)